Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Cardiovascular Systems, Inc.    CSII

CARDIOVASCULAR SYSTEMS, INC.

(CSII)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
03/23/2020 03/24/2020 03/25/2020 03/26/2020 03/27/2020 Date
30.19(c) 33.13(c) 32.93(c) 34.59(c) 33.96(c) Last
411 400 355 714 424 434 316 316 223 378 Volume
+0.63% +9.74% -0.60% +5.04% -1.82% Change
More quotes
Financials (USD)
Sales 2020 282 M
EBIT 2020 -6,19 M
Net income 2020 -6,19 M
Debt 2020 -
Yield 2020 -
Sales 2021 317 M
EBIT 2021 4,37 M
Net income 2021 4,02 M
Debt 2021 -
Yield 2021 -
P/E ratio 2020 -187x
P/E ratio 2021 297x
Capi. / Sales2020 4,25x
Capi. / Sales2021 3,77x
Capitalization 1 197 M
More Financials
Company
Cardiovascular Systems, Inc. is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial... 
More about the company
Surperformance© ratings of Cardiovascular Systems, In
Trading Rating : Investor Rating :
More Ratings
Latest news on CARDIOVASCULAR SYSTEMS, IN
02/18CARDIOVASCULAR SYSTEMS, INC. : to Participate at Three Upcoming Investor Confere..
BU
02/06CARDIOVASCULAR : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND..
AQ
02/05CARDIOVASCULAR SYSTEMS : Fiscal 2Q Earnings Snapshot
AQ
02/05CARDIOVASCULAR SYSTEMS INC : Results of Operations and Financial Condition, Fina..
AQ
02/05CARDIOVASCULAR SYSTEMS, INC. : Reports Fiscal 2020 Second-Quarter Financial Resu..
BU
01/15CARDIOVASCULAR SYSTEMS, INC. : to Webcast Fiscal 2020 Second-Quarter Earnings Co..
BU
2019CARDIOVASCULAR SYSTEMS, INC. : Introduces Peripheral Orbital Atherectomy System ..
BU
2019BAYER : to Work With Dewpoint Therapeutics to Develop New Therapies
DJ
2019CARDIOVASCULAR SYSTEMS INC : Change in Directors or Principal Officers, Financia..
AQ
2019CARDIOVASCULAR SYSTEMS, INC. : Announces Stephen Stenbeck Joins Board of Directo..
BU
2019FibroGen, AstraZeneca Up After Roxadustat Data
DJ
2019CARDIOVASCULAR SYSTEMS, INC. : to Present at the Stifel 2019 Healthcare Conferen..
BU
2019CARDIOVASCULAR : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND..
AQ
2019CARDIOVASCULAR SYSTEMS INC : Results of Operations and Financial Condition, Fina..
AQ
2019CARDIOVASCULAR SYSTEMS : Fiscal 1Q Earnings Snapshot
AQ
More news
News in other languages on CARDIOVASCULAR SYSTEMS, IN

- No features available -

More news
Chart CARDIOVASCULAR SYSTEMS, INC.
Duration : Period :
Cardiovascular Systems, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CARDIOVASCULAR SYSTEMS, IN
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 9
Average target price 52,40  $
Last Close Price 33,96  $
Spread / Highest target 88,5%
Spread / Average Target 54,3%
Spread / Lowest Target 6,01%
EPS Revisions
Managers
NameTitle
Scott R. Ward Chairman, President & Chief Executive Officer
Rhonda J. Robb Chief Operating Officer
Jeffrey S. Points Chief Financial Officer
Ryan D. Egeland Chief Medical Officer
Augustine J. Lawlor Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
CARDIOVASCULAR SYSTEMS, INC.-30.11%1 197
MEDTRONIC PLC-20.77%120 468
BAXTER INTERNATIONAL INC.-4.58%40 470
HOYA CORPORATION-2.44%35 360
TERUMO CORPORATION-0.06%25 583
DEXCOM, INC.20.22%24 086